#Ophthalmology Medicine Franchise Company

[opdenaslifesciences]

About Our Company: The Opdenas Lifesciences Company is a pharmaceutical franchise company located in Zirakpur, India. We provide business opportunities for Ophthalmic PCD Pharma Franchise Companies in India. A large portion of our business is dealing with Ophthalmic Pharma Franchise Companies across India. As one of the leading Ophthalmic PCD Pharma Franchise Companies in the city, we have a long history of providing quality healthcare.

Opdenas Lifesciences has wide range of Eye Drops, Nasal Drops & Ear Drops (ENT Products). Opdenas Lifesciences dedicatedly deals in Eye Drops Range. On the other hand, We have three divisions, in which Mediganza Heathcare deals in a wide range of Allopathic, Ayurvedic or Herbal , Veterinary and Eye Drops Products. Mediganza Healthcare has a wide range of Allopathic, Ayurvedic, Veterinary and Eye Drops. Third Division, Vee Remedies dedicatedly deals in Veterinary Products and Feed Supplement. 

Click here- Ophthalmic PCD Pharma Franchise Company

[eyerisvision]

Best Pan India Level Eye Drops Supplier in India

Best Pan India Level Eye Drops Supplier in India - Best Eye Drops Supplier in India is in high demand. A large section of the Indian population suffers from minor to serious eye diseases. People are looking for the best solution for a healthy lifestyle. Today, people are aware of their health and always want to be fit for a better life. The best facelift suppliers in India are working hard to fulfill this requirement. Eyeris Vision Care is one of the best eye drops suppliers in India known for best eye drops in India. Looking at the increasing demand, it can be said that this is a great opportunity to start a successful PCD ophthalmic medicine business in India.

So, if you are waiting for the Best Pan India Level Eye Drops Supplier in India, contact Eyeris Vision Care. Call us at 91-9034803607 or email us at eyerisvisioncare@gmail.com 

The Best Pan India Level Eye Drops Supplier in India - Eyeris Vision Care

Eyeris Vision Care is known as the best eye drop supplier in India. We have a reputation and many years of experience in the pharmaceutical industry. We provide the best quality eye drops in India and the best PCD Pharma Franchise services for Ophthalmology at the Pan India level. All our products have the highest quality certification and are manufactured using the latest and best technologies. Being one of the leading pharmaceutical companies in India, Eyeris Vision Care is proficient in a wide range of ophthalmic products and more. All our products are certified and certified according to high-quality standards such as (WHO), (GMP) Good Manufacturing Practice and (ISO) International Organization for Standardization. All products are launched after approval by the QA/QC department.

Scope of Eye Drops in India

Spending a lot of time in front of harmful UV rays, mobile screens, televisions, computers, and laptops has caused many eye problems such as dry eye, gout, eye disease, and blurred vision. As people become more aware of eye health, they want a variety of eye drops suitable for different eye conditions. Globally, the market size will decrease from $17.7 billion in 2024 to $25.8 billion in 2034 at a CAGR of 4.7%. This is the right time to commence an Ophthalmic PCD Pharmaceutical Franchise Business in India.

Why Opt Eyeris Vision Care for the Best Eye Drop Supplier in India

Eyeris Vision Care is a specialty eye care pharmaceutical company. We are recognized as the number one ophthalmology organization for premium eye products in the most effective class. We are expanding the PCD Pharma franchise to the entire ophthalmic sector in India by partnering with pharmaceutical experts. At our company, experienced professionals try to provide complete solutions for many eye problems.

Contact Details

Name - Eyeris Vision Care 

Phone Number - 91-9034803607

Address - SCO-4, New Defence Colony, Patiala Road, Zirakpur-140603

Email - eyerisvisioncare@gmail.com 

[aventurahealthcare]

Best ophthalmic pharma Franchise in India

Aventura Healthcare is well-known in the pharmaceutical world. They are considered the Best ophthalmic pharma Franchise in India. This is because they focus on eye health and offer top-quality products to help people see better.

Aventura Healthcare provides a wide range of eye care products. These include eye drops, ointments, and other medicines that treat different eye conditions. Their products are made with the highest standards, ensuring safety and effectiveness. This dedication to quality has made Aventura Healthcare a trusted name among doctors and patients.

One of the reasons Aventura Healthcare is the Best ophthalmic pharma Franchise in India is their commitment to research and development. They are always looking for new ways to improve their products. By using the latest technology and scientific research, they create medicines that are not only effective but also safe to use.

Customer satisfaction is very important to Aventura Healthcare. They work closely with their franchise partners, offering support and training to ensure that everyone involved can provide the best service possible. This helps to maintain high standards and ensures that patients receive the best care.

Aventura Healthcare also values ethical business practices. They follow strict rules and regulations, ensuring transparency in all their operations. This honesty and integrity have earned them the trust of both healthcare professionals and patients.

In conclusion, Aventura Healthcare stands out as the Best ophthalmic pharma Franchise in India because of their commitment to quality, innovation, and customer satisfaction. Their focus on eye health and their dedication to ethical practices make them the top choice for anyone looking to partner with a leading pharmaceutical company in the field of ophthalmology.

[grevispharma]

Why Eye Drops Franchises Are a Smart Investment Opportunity

There are a few Pharma Franchise organizations who are giving the Eye Drop Franchise Company. These days individuals are more into their day-to-day employment. Thus, We are providing a wonderful opportunity for the eye drop franchise business. Thus, you can get this opportunity by joining a hand with the leading company Grevis Pharma.

Grevis Pharma is one of those companies which is lasted for 15 years. The company is situated in Gurgaon but provides franchise opportunities all around PAN India, we now become the best in the market and well know ophthalmic company in the market, and we supply excellent Eye drop products that meet all the global standards that are needed to cure the disease. However, we aim to provide the best inline product in the market as well as provide value to the customers.

Grab this wonderful opportunity from us

A trusted brand for the last 15 years has built various aspects of the industry of ophthalmic and attained many awards. But, trusting a company that you are going to partner with is the only company that is going to increase your value. So, make sure that you choose that Eye Drop Manufacturing Company who would be rewarded for you.

A leading brand Grevis Pharma has many figures that were attained like we have 10+ manufacturing units, 250 channel partners with 450 products registered, and 5000 ophthalmologists. Moreover, we focus on providing value to our customers with the top-notch of quality.  Here are some of those which is needed and found in the top EYE DROP PCD Franchise business:

The Company should give In-depth knowledge of the Pharma Industry

Monopoly right is the biggest advantage that most of the company gives to their associations and it is the most important factor for those who want to scale their PCD business.

100% Satisfaction is also considered in terms of providing the product.

The franchise company must have the good and the widest chain for the logistics.

The company must provide 24x7 customer support to their company.

The company should run quality tests for the medications and all.

There should be those employees in the company who are willing to provide 100% in the works as well all should have rich experience in the ophthalmologic niche.

Our quality assurance engineers work around the clock.

Our medicines and eyedrops range have accurate composition.

Conclusion

To conclude, the thing for the PCD pharma franchise especially in the Eye Drop. We are the leading eye drops franchise in India. Thus you can take advantage of taking the pharma franchise in a better entitlement company that provides the best in all aspects.

[preetiken]

Philippines Pharmacy Retail Market is anticipated to grow by USD 6Th Mn by 2025- How will the market gain traction to be able to reach at its targeted number?

The government distribution of medicines will improve in future due to the initiatives such as Botika Ng Bayan, Distribution through Local Health Units and Rural Health Units, says a report by Ken Research

1.Corona Virus effect on pharmacy sales in Philippines Pharmacy Retail Market.

Other Challenges in Philippines Pharmacy Retail Market Outlook to 2025

Demand for OTC products like Alcohol Based Cleaners, Vitamin C and D Tablets, Immunity Boosters and Health Supplements was boosted during quarantine. Maintenance Medicines were also in high demand. During the starting of the Quarantine, Pharmacies witnessed increase in sales due to bulk purchase, later the sales declined. Pharmacies faced supply chain issues especially in the ECQ zones. This has affected the sales of the pharmacies. Further, Philippines witnessed lockdown for a long duration.

2.Trends and Development that the Pharmacy retail market of Philippines will experience.

Download Sample Report

In July 2018, DOH relaunched Botika Ng Bayan initiative to provide free essential medicines for common diseases focusing on rural and poor people. The chain stores have increased tremendously in the Philippines. Especially TGP and Generika as they have adopted franchise model for store expansion. This increase in chained pharmacies has led to the growth of house brands or private labels. In starting of 2019, President Rodrigo signed Universal Health Care (UHC) Bill into law (Republic Act No. 11223) which automatically enrolls all Filipino citizens in the National Health Insurance Program. This will increase the healthcare affordability in the region.

3. Assessing the Possibilities in the Philippines Pharmacy Retail Market

Ask For Customization

Penetration of internet, growth of social media has opened more connectivity options for the companies.

Drive Through Stores, self-service stores are increasing customer convenience.

This has helped in increasing the footfall in pharmacies for purchasing non pharmaceutical products.

Chain stores can serve regional customers where they don’t have strong presence.

Key Segments Covered

By Market Structure (In USD Billion)

Organized Market

Unorganized Market

Type of Store Location (In USD Billion)

Standalone Pharmacy

Hospital Based Pharmacy

By Region (In USD Billion)

North

Central

South

By Type of Sales (In USD Billion)

Prescribed Medicines

OTC Products

Non Pharmaceutical Products

Medical Equipment

By Type of Drug (In USD Billion)

Generic

Patented

By Therapeutic Class (In USD Million)

Cardiovascular

Anti-Infectives

Pain/Analgesics

Anti Diabetic

Vitamins/Minerals /Nutrients

Dermatology

Respiratory

Gastro Intestinal

Neuro

Oncology

Contraceptive

Gynecological

Ophthalmological

Others

Companies Covered

Mercury Drug Corporation

Watsons Personal Care Stores

SouthStar Drug Inc.

The Generics Pharmacy

Rose Pharmacy

Generika Drugstores

Several Regional Players & Others

Key Target Audience

Pharmaceutical Manufacturer Companies

Pharmaceutical Importing Companies

Pharmaceutical Distributing Companies

Major Retail Companies

E-Commerce Pharmaceutical Retailers

Consultancy Companies

Industry Associations

Regulation Bodies

Time Period Captured in the Report:

Historical Period: 2014-2019

Forecast Period: 2020-2025

Key Topics Covered in the Report

Healthcare System in the Philippines

Major Hospitals & Doctors in the Women Healthcare      

Usage of Contraception & Family Planning in the Philippines

Health Insurance in the Philippines

Supply Structure of the Philippines Pharmacy Retail Market

Trends & Development in the Philippines Pharmacy Retail Market

Issues & Challenges in the Philippines Pharmacy Retail Market

SWOT Analysis & BCG Matrix in the Philippines Pharmacy Retail Market

Philippines Pharmacy Retail Market Size & Segmentation, 2014-2019

Online Pharmacy Regulations in the Philippines

Telemedicine & Growth of Online Medical Consultation in the Philippines

Major Telemedicine Providers in the Philippines

Operating Model of Hybrid Pharmacies

Competition Scenario, Market Share, Cross Comparison of Major Players (Online & Offline) and Company Profile

Assessing Regional Pharmacies in the Philippines

Corona Virus Impact on the Consumer Behavior & Pharmacy Sales

Future Market Size and Segmentations, 2019-2025F

Covid 19 Impact on the Philippines Pharmacy Retail Market

Analysts’ Recommendations

Contact us:

Ankur Gupta, Head of Marketing and Communications

support@kenresearch.com

+91-9015378249

Follow Us

Facebook | Twitter | LinkedIn | Instagram

[riyadhpharmaceuticals]

Riyadh Pharmaceutical is the leading and fastest-growing pharmaceutical company in the PCD pharma franchise marketplace. We are the Best Eye Drops PCD Companies in India. Find Here List of Ophthalmology Medicine Franchise Company. There are a number of pharma companies in India that provide the Ophthalmic Medicine PCD Company. But Riyadh Pharmaceutical is the only pharma company that provides more the 350 Ophthalmic products for PCD Franchise businesses at the Pan India level.

[pharmaflair]

Discover 2000+ Opthalmic products manufactured in WHO GMP Guidelines for PCD franchise in India. Connect with Top Ophthalmology Companies for wholesale licensed trading, Third Party Manufacturing, Contract Manufacturing in India.

[pharmahealthcare]

Pharmaceutical | Ayurvedic | Dermatology | Cardiac | Ophthalmology Products |Third Party Manufacturing Company in India

Delwis Healthcare is a leading pharma manufacturer of pharmaceutical products in India. Pharma offers WHO-GMP certified products to its customers. Delwis Healthcare is among the best pharmaceutical company & third party pharma manufacturing company in India.

Dev Eye Care is an India's Leading Ophthalmology Pharma Company for PCD & Third Party Pharma Manufacturing Industry. We are the best Ophthalmology Pharma Company In India.

India's Leading Dermatology Pharma Company for PCD & Third Party Pharma Manufacturing & world's pharmaceutical industry in India.

Products & Services: Pharmaceutical, Ayurvedic, Dermatology, Cardiac, and Ophthalmology is the Best Third-Party Pharma Manufacturer company based in Ahmedabad, Gujarat, India.

Sonshree Ved is an India's Leading Ayurvedic Pharma Company for Ayurvedic Medicines & Products. We at on top stage of the best Ayurvedic Company In India.

Cardetics is India's Leading Cardiac & Diabetic Pharma Company, We are Cardiac and Diabetic PCD company and high-quality drug manufacturer according to standards set by WHO-GMP in India Offering Cardiac Diabetic Products Franchise.

PCD Pharma Company in India, Best Pharma Franchise Company in India, Third Party Manufacturing in India.

[xenonpharma]

Pharma Franchise for Ophthalmology

Do you want the best ophthalmic medicines in hisar, India? Xenon Pharmaceuticals is a leading and a reputed PCD Pharma franchise company for Ophthalmology.

[nayanvision21]

List of Best Eye Drops Franchise Companies in India

List of Best Eye Drops Franchise Companies in India – The Indian Ophthalmic Sector is growing at a rapid pace because of the ample demand for Eye Drops in the market. There are a number of pharmaceutical companies that have started dealing in the eye drop range after observing the continuous market demand. Due to this, many business investors also aim to invest in this particular sector with an aim to earn lavishing profits. If you are also one who is trying hard to find a reliable company to associate with, then this blog can help you out in many ways. We have come up with the List of Best Eye Drops Franchise Companies in India.

Nayan Vision

An ISO 9001:2015 Certified company Nayan Vision is a widely recognized healthcare organization that specializes in delivering an ample range of high-quality eye drops. The company is firmly committed to manufacturing, exporting, and supplying a highly pure, safe, and affordable range of ophthalmic products across the nation. They adhere to a set of quality assurance norms that comply with Global Quality Criteria. Due to its reach to fulfill customers’ requirements, the company is considered the Best Eye Drops Franchise Company in India.

Usage of modernized devices and tools to bring out optimal outcomes.

Frequent updates and upgrades in the product catalog with continuous developments.

Well-furnished quality control equipment to detect precise quality.

Operated by an expert panel that makes sure 100% quality assurance.

Medlock Healthcare

If you are in a serious search of a trustable ophthalmic company that not only provides rich quality eye drops but also offers impressive franchise deals, then you must not miss out on Medlock Healthcare. The company serves complete transparency in its mutual marketing agreements with the guarantee of huge growth opportunities and escalated profit margins. They keep on adding new eye drop formulations to their product list as per the current and future market demands of people.

Vee Remedies

Jumping to number three in the list of Best Eye Drops Franchise Companies in India, we have Vee Remedies. Vee Remedies is a highly reputable pharmaceutical company that deals in a wide variety of medicinal categories including tablets, suspensions, eye drops, syrups, nasal drops, and much more. The company is known for the purity, safety, effectiveness, and long shelf life of its eye drops. They formulate their compositions under GMP norms and in cutting-edge manufacturing plants.

Novalab Healthcare

Novalab Healthcare is a significant player in the pharmaceutical industry that has been engaged in producing high-end quality and effective pharma products. With its customer-oriented approach, the company has earned the trust and respect of all its clients and customers who rely on them for the safest medicines. They work with certain protocols and values that allow them to provide their best in the market. They source the raw materials from Industry’s top vendors and merchants.

Zexus Pharma

Zexus Pharma is a famed name in the field of ophthalmology that holds its own manufacturing facilities that are approved by WHO-GMP authorities. The company has a world-class infrastructure that is well-segregated into various departments including warehouses, quality control laboratories, R&D zones, packaging areas, and a lot more. They are also engaged in providing irresistible franchise opportunities to all its business associates along with superlative benefits of monopoly rights, attractive packaging, on-time delivery, and affordable prices.

Conclusion

So, the above discussed are the Best Eye Drops Franchise Companies in India that are gaining optimum success and recognition in the Indian Ophthalmic Market. You can make a convenient choice of associating with a company for your own business in this segment. But if you want to get hands-on the premium quality eye drops along with manifold business benefits, then come in contact with the Best Eye Drops PCD Franchise Company in India, Nayan Vision.

[ka43270]

Asia-Pacific Ophthalmology Devices Market Industry Applications, Products and Business Opportunity

Market Analysis and Insights: Asia-Pacific Ophthalmology Devices Market

Asia-Pacific Ophthalmology Devices Market, By Product Type (Vision Care Devices, Surgery Devices and Diagnostic and Monitoring Devices), Application (Vision Care, Ophthalmic Woundcare, Cataract Surgery, Oculoplastics and Others), End User (Hospitals, Diagnosis Clinics, Franchise Optical Stores, Eye Research Institutes, Government Agencies and Academics), Geography (Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia Pacific) - Industry Trends and Forecast to 2026

If you are an investor/shareholder in Asia-Pacific Ophthalmology Devices Market, the provided study will help you to understand the growth model Asia-Pacific Ophthalmology Devices Market after the impact of COVID-19.  Request for sample report@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-ophthalmology-devices-market

Ophthalmology is the study of the eye and its various conditions, it is a branch of medicine that deals with the treatment, cure and diagnosis of various diseases of the eye and visual mechanism. The term ophthalmology originated from the Greek words ophthalmos which means “eye” and logos which means “word.” This means the “science of eyes.” The human eye can be affected by various clinical conditions like: Age-related macular degeneration, cataract, diabetic retinopathy, glaucoma and astigmatism.

The ophthalmoscope was introduced in the 19th century which bought along a period of deep knowledge of the eye and treatment of various eye related diseases that was not possible before. Later, throughout the 20th century, investigation in the field of ophthalmology kept growing and several subspecialties were introduced. In 1805, Moorfields Eye Hospital became the first hospital that was dedicated to ophthalmic opened in London.

Asia-Pacific Ophthalmology Devices Market is expected to register a healthy CAGR of 5.4% in the forecast period of 2019 to 2026.

 Inquire before the purchasing report –@https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=asia-pacific-ophthalmology-devices-market

Segmentation: Asia-Pacific Ophthalmology Devices Market

Asia-Pacific ophthalmology devices market is segmented into three notable segments such as product type, application and end-user.

 In October 2018, HOYA surgical optics      to acquire two ophthalmic medical Device companies: mid labs and fritz      ruck. The acquisition will expand HOYA Surgical Optics’ technology      portfolio in surgical ophthalmology to encompass a very attractive and      competitive offering within cataract surgery.

 In September 2017, Marco launched the      Ultra M Series slit lamps, LM-7 Lensmeter Series, and TS-310 Tabletop      Refractive Workstation at VEW 2017. This helped Marco expand its product      portfolio and penetrate deeper into the market.

 In November 2018, Haag-Streit and      Berkeley School of Optometry Announced New Partnership. This helped      students to be trained on the best medical and diagnostic equipment from      the start and will give a new customer base to Haag-Streit.

 Get Detailed Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-ophthalmology-devices-market

Competitive Analysis: Asia-Pacific Ophthalmology Devices Market

Some of the major players operating in this market Essilor,  Marco, Heidelberg Engineering GmbH.,  HAAG-STREIT GROUP, Johnson & Johnson Surgical Vision, Inc., HOYA Corporation., CIBA VISION, NIDEK CO., LTD., TOPCON CORPORATION, ZEISS International, Canon Inc., CooperVision, Bausch & Lomb Incorporated., STAAR SURGICAL, AcuFocus, Inc., Ziemer Ophthalmic Systems among others.

Product Launch:

In September 2018, NIDEK launched the     GS-1 Gonioscope. This helped NIDEK to expand its product portfolio.

In January 2018, HOYA surgical optics     launches new global research and development centre in Singapore to     address global burden of cataract. This will help HOYA Surgical Optics the     first IOL company with an integrated hub in Singapore.

In March 2018, CooperVision Announced     the Availability of New MyDay toric in Plus Powers. This will help     CooperVision to make increase their product portfolio.

Research Methodology: Asia-Pacific Ophthalmology Devices Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Doctors, Nurses, Medical practitioners. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.

Browse more related report to know about market analysis

Asia-Pacific     Flexible Digital Video Cystoscopes Market

Asia-Pacific     Intraoperative Imaging Market

Asia-Pacific     Skin Tightening Market

Dental     Diagnostic & Surgical Equipment Market

Europe     Cardiac Pacemakers Market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact: Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

[eyerisvision]

Best Eye Drops PCD Franchise in India

Best Eye Drops PCD Franchise in India - If you want to build a successful business, starting the Best Eye Drops PCD Franchise in India would be a great idea. This business is increasing in productivity and demand due to more time spent in front of screens and eye problems for many reasons. Eyeris Vision Care is India's leading PCD eye drop manufacturer that manufactures and supplies a wide range of eye drops.

Significance of Eye Drop PCD Franchise in India

Investing in a PCD corporation in various eye drops in India will be good for your prospects as we provide all the services that play an important role in the growth and height of the industry. The pharmaceutical industry plays an important role in India's corporate society. Pharma is a broad term that covers a wide range of products and classifications. An increasing number of companies are interested in this industry because it is diverse and offers many opportunities for participation. More and more companies are interested in this industry because it is diverse and offers many opportunities for participation. India is currently witnessing rapid growth in the eye care field and is predicted to grow further.

The Best Eye Drops PCD Franchise in India - Eyeris Vision Care

Eyeris Vision Care is one of India's most trusted and popular eye drops corporations. Because we are known for producing high-quality eye drops and other eye products. In addition to a wide variety of eye drops, we offer great business and promotional support and career opportunities. According to Vee Remedies, these products are manufactured by WHO (World Health Organization) and GMO standards using the latest technology and quality control procedures to ensure the potency and safety of our products. We promise and strive to provide innovative and effective vision care solutions for people suffering from eye problems. Below are some of the key features that set us apart from other ophthalmology companies:

We give our business partners full control over how to set up their pharmaceutical business, trademark, and product name as an independent business owner. 

The pace of business, the innovative approach, and the aim to meet the needs of people for ophthalmic facilities set us apart from other PCD pharmaceutical companies. 

Exclusive right to buy medicine in the desired market, facilities certified by GMP and WHO at pocket-friendly rates.

Business Opportunity at India’s leading eye drops PCD pharma company, Eyeris Vision Care

Our main goal is to provide eye care products under the guidance of highly trained professionals to achieve excellence in quality, safety, efficacy, and total customer satisfaction. We exclusively focus on distributing eye medicines to people across the country at an affordable price. We offer exclusive monopoly rights for sales and distribution in the region.

Contact Details

Name: Eyeris Vision Care

Phone Number: +91-9034803607

Address: SCO-4, New Defence Colony, Patiala Road, Zirakpur-140603

Email: eyerisvisioncare@gmail.com  

[pharmaphorumuk]

Bayer slides on €9.5bn loss caused by litigation, COVID-19 impact

Bayer counted the cost of its expensive Roundup weedkiller settlement in the second quarter with a €9.5 billion net loss made worse by lower sales in its pharma and consumer health divisions.

Group sales were down 2.5% to just over €10 billion, with pharma falling 8.8% to just under €4 billion, “weighed down” by COVID-19 and China’s new volume-based procurement policy for healthcare products.

Shares in Bayer were on the slide in mid-morning trading after the figures were announced, down a little over 3%.

In common with many of its peers, Bayer saw an uptick in pharma sales in the first quarter in part due to stockpiling of medicines as the coronavirus pandemic gathered momentum.

Like others it has also been hit by the effects of lockdowns on prescribing rates in the second quarter – with women’s health, ophthalmology and radiology products hit the hardest as consultation rates plummeted – but says it saw glimmers of a recovery at the end of the period.

There was a sizable fall for Eylea (aflibercept) for age-related macular degeneration (AMD), Bayer’s second-biggest product which declined 6% to €568 million, but the contraceptive franchise was hit hardest, down more than €110 million on the same period last year to €185 million.

Gains for top-seller Xarelto (rivaroxaban), Bayer’s oral anticoagulant, and cancer drug Stivarga (regorafenib) offset the declines, aided by the earlier return to some degree of normality in China in the second quarter as the pandemic eased.

Consumer health sales also dipped 1.9%, falling back after a strong first quarter driven by consumer purchasing over-the-counter medications amid the COVID019 crisis.  

The headline news for the German company however was the near $11 billion deal agreed in June to settle claims, inherited after its $66 billion takeover of agricultural products company Monsanto, that its Roundup herbicide causes cancer.

The settlement covered around three quarters of all current lawsuits – estimated to number around 125,000 – and also includes a capped amount for any that emerge in the future.

Taking out the settlement charge, Bayer says it would have posted a 5.6% increase in earnings to nearly €2.9 billion.

Essure litigation still lingering

While the Roundup litigation should be in its rear-view mirror, Bayer had to include a provision in its second-quarter accounts for litigation relating to birth control device Essure.

The company took a charge of more than €1.5 billion in the period “that mainly comprised expenses in connection with the Essure litigation,” with 32,000 lawsuits ongoing alleging injury from the device as of 24 July.

Plaintiffs claim birth control with Essure led to side effects including hysterectomy, pain, bleeding, weight gain, depression and unwanted pregnancies.

Looking to the full-year, Bayer says the financial impact of the COVID-19 pandemic “remains difficult to predict.”

It expects a recovery in pharma and consumer health, but doesn’t think they will bounce back to earlier forecast growth, and is trimming its group sales forecasts for the year by €1 billion to €43-€44 billion.

The post Bayer slides on €9.5bn loss caused by litigation, COVID-19 impact appeared first on .

from https://pharmaphorum.com/news/bayer-slides-on-e9-5bn-loss-caused-by-litigation-covid-19-impact/

[pharmafranchiseeindia]

consisting of top ophthalmology Medicine Company, ophthalmology drugs PCD and pharmaceutical medicine franchise companies with monopoly rights in India.

[riyadhpharmaceuticals]

[pharmaflair]

Eye infection are very common in India, to treat these infectious diseases Pharma Companies are manufacturing WHO GMP wide range of Ophthalmic Medicine & Eye drops Range at best Price in India.